Literature DB >> 850132

Modulation of phagocytosis by and lysosomal enzyme secretion from guinea-pig neutrophils: effect of nonsteroid anti-inflammatory agents and prostaglindins.

R J Smith.   

Abstract

Guinea-pig neutrophils released lysosome granule-associated beta-glucuronidase, but not cytoplasmic lactate dehydrogenase during cell contact with and phagocytosis of serum-treated zymosan particles. Naproxen, chloroquine and indomethacin inhibited particle uptake by and lysosomal enzyme secretion from neutrophils incubated with zymosan in Krebs-Ringer phosphate medium, pH 7.4, at 37 degrees C. Acetylsalicyclic acid, fenoprofen and ibuprofen were inactive. Prostaglandins (PG) E1, E2, A1, A2, B1 and B2 reduced particle ingestion by and discharge of lysosomal enzymes from neutrophils. PGF2alpha accelerated lysosomal enzyme release, had no effect on phagocytosis at high concentrations and inhibited both processes at low concentrations.. PGF1alpha was inactive. In the presence of cytochalasin B, an agent which inhibits phagocytosis while havine no effect on selective lysosomal enzyme secretion, naproxen, chloroquine and indomethacin, continued to inhibit the discharge of beta-glucuronidase from neutrophils. PGE1, PGE2, PGA1, PGA2, PGB1 and PGB2 reduced lysosomal enzyme release from cytochalasin B-treated neutrophils. PGF2alpha accelerated at high and inhibited at low concentrations the selective secretion of beta-glucuronidase from cytochalasin B-treated neutrophils. PGF1alpha was again inactive. These studies indicated that guinea-pig neutrophils are capable of a selective release of lysosomal enzymes (beta-glucuronidase) during ingestion of serum-treated zymosan particles and that certain anti-inflammatory drugs and prostaglansins may function as modulators of the phagocytic release of lysosomal enzymes from neutrophils.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850132

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

1.  Anti-inflammatory properties of prostaglandin E2: deletion of microsomal prostaglandin E synthase-1 exacerbates non-immune inflammatory arthritis in mice.

Authors:  Andrey Frolov; Lihua Yang; Hua Dong; Bruce D Hammock; Leslie J Crofford
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-08-30       Impact factor: 4.006

Review 2.  Regulation of immune responses by prostaglandin E2.

Authors:  Pawel Kalinski
Journal:  J Immunol       Date:  2012-01-01       Impact factor: 5.422

3.  Drug and rheumatoid factor effects on the uptake of immunoglobulin G aggregates by neurtrophil monolayers.

Authors:  R Turner; G Counts; H Mashburn; W Treadway; L DeChatelet
Journal:  Inflammation       Date:  1980-03       Impact factor: 4.092

4.  The anti-inflammatory profile of dapsone in animal models of inflammation.

Authors:  A J Lewis; D K Gemmell; W H Stimson
Journal:  Agents Actions       Date:  1978-12

5.  Chloroquine: its effect on leucocyte auto- and heterophagocytosis.

Authors:  C J Jones; M I Jayson
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

6.  The effect of prostaglandins on experimental storage disease in rats.

Authors:  K Joh; U N Riede; H P Zahradnik
Journal:  J Exp Pathol (Oxford)       Date:  1990-04

7.  The effect of prostaglandins on the lysosomal function in the cervix uteri.

Authors:  K Joh; U N Riede; H P Zahradnik
Journal:  Arch Gynecol       Date:  1983

8.  Activation of the human neutrophil secretory process with 5(S),12(R)-dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid.

Authors:  R J Smith; S S Iden; B J Bowman
Journal:  Inflammation       Date:  1984-12       Impact factor: 4.092

9.  A morphological study of the effects of indomethacin, flufenamate, salicylate and calcium ions on rabbit peritoneal neutrophil polymorphs.

Authors:  A M Northover
Journal:  Br J Exp Pathol       Date:  1981-08

10.  Time-dependent stimulatory and inhibitory effects of prostaglandin E1 on exudative and tissue components of granulomatous inflammation in rats.

Authors:  I L Bonta; M J Parnham
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.